<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37024311</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1972</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of adolescent health : official publication of the Society for Adolescent Medicine</Title><ISOAbbreviation>J Adolesc Health</ISOAbbreviation></Journal><ArticleTitle>A Cross-Sectional Study of the Health of Emerging Young Adults in England Following a COVID-19 Infection.</ArticleTitle><Pagination><StartPage>20</StartPage><EndPage>28</EndPage><MedlinePgn>20-28</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jadohealth.2023.01.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1054-139X(23)00076-9</ELocationID><Abstract><AbstractText Label="PURPOSE">This study describes long COVID symptomatology in a national sample of 18- to 20-year-olds with Polymerase Chain Reaction (PCR)-confirmed Severe acute respiratory syndrome coronavirus 2 (SARS&#x2011;CoV&#x2011;2) and matched test-negative controls in England. Symptoms in 18- to 20-year-olds were compared to symptoms in younger adolescents (aged 11-17&#xa0;years) and all adults (18+).</AbstractText><AbstractText Label="METHODS">A national database was used to identify SARS-CoV-2 PCR-positive 18- to 20-year-olds and test-negative controls matched by time of test, age, gender, and geographical region. Participants were invited to complete a questionnaire about their health retrospectively at time of test and also when completing the questionnaire. Comparison cohorts included children and young people with long COVID and REal-time Assessment of Community Transmission studies.</AbstractText><AbstractText Label="RESULTS">Of 14,986 people invited, 1,001 were included in the analysis (562 test-positive; 440 test-negative). At testing, 46.5% of test-positives and 16.4% of test-negatives reported at least one symptom. At the time of questionnaire completion (median 7&#xa0;months post-testing), 61.5% of test-positives and 47.5% of test-negatives reported one or more symptoms. The most common symptoms were similar amongst test-positives and test-negatives and included tiredness (44.0%; 35.7%), shortness of breath (28.8%; 16.3%), and headaches (13.7%; 12.0%). Prevalence rates were similar to those reported by 11-17-year-olds (66.5%) and higher than those reported in all adults (37.7%). For 18- to 20-year-olds, there was no significant difference in health-related quality of life and well-being (p &gt; .05). However, test-positives reported being significantly more tired than test-negatives (p&#xa0;= .04).</AbstractText><AbstractText Label="DISCUSSION">Seven months after PCR test, a high proportion of test-positive and test-negative 18- to 20-year-olds reported similar symptoms to each other and to those experienced by younger and older counterparts.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Newlands</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom. Electronic address: fiona.newlands.18@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Natalia K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nugawela</LastName><ForeName>Manjula</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto Pereira</LastName><ForeName>Snehal M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Surgery &amp; Interventional Science, Faculty of Medical Sciences, University College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buszewicz</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Department of Primary Care &amp; Population Health, Faculty of Population and Health Sciences, University College London, Royal Free Campus, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalder</LastName><ForeName>Trudie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Emily Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalrymple</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Tamsin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Hershel Smith Building Cambridge Biomedical Campus, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Paediatric Infectious Diseases Research Group, St. George's University of London, Cranmer Terrace, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McOwat</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immunisation Department, Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Adolesc Health</MedlineTA><NlmUniqueID>9102136</NlmUniqueID><ISSNLinking>1054-139X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Emerging adults</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>6</Day><Hour>21</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37024311</ArticleId><ArticleId IdType="pmc">PMC9910021</ArticleId><ArticleId IdType="doi">10.1016/j.jadohealth.2023.01.026</ArticleId><ArticleId IdType="pii">S1054-139X(23)00076-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Esakandari H., Nabi-Afjadi M., Fakkari-Afjadi J., et al. A&#xa0;comprehensive review of COVID-19 characteristics. Biol Proced Online. 2020;22:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402395</ArticleId><ArticleId IdType="pubmed">32774178</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R.M., Ward J.L., Hudson L.D., et al. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch Dis Child. 2021;106:802&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">33334728</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  A&#xa0;clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 Available at:</Citation></Reference><Reference><Citation>Ayoubkhani D., King S., Pawelek P. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 7 July 2022. 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7july2022 Available at:</Citation></Reference><Reference><Citation>Wu Q., Ailshire J., Crimmins E. Long COVID and symptom trajectory in a representative sample of Americans. Res Sq. 2022;12:11647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9264749</ArticleId><ArticleId IdType="pubmed">35804058</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;31:1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13:3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. 2020;106:429&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">33262177</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pinto Pereira S.M., Shafran R., et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. The Lancet Child Adolesc Health. 2022;6:230&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati H., Shahisavandi M., et al. Long COVID in children and adolescents. World J Pediatr. 2021;17:495&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Dam Nielsen S., Nygaard U., et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc Health. 2022;6:240&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Ayuzo Del Valle N.C., et al. Long-COVID in children and adolescents: A systematic review and meta-analyses. Sci Rep. 2022;12:9950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddux A.B., Berbert L., Young C.C., et al. Health impairments in children and adolescents after Hospitalization for acute COVID-19 or MIS-C. Pediatrics. 2022;150</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281852</ArticleId><ArticleId IdType="pubmed">35765138</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S.D., et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J&#xa0;Infect. 2022;84:158&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler K., Vizard T., Ford T., et al.  Mental Health of Children and Young&#xa0;People in England, 2017, Summary of key findings. https://dera.ioe.ac.uk/32622/1/MHCYP%202017%20Summary.pdf Available at:</Citation></Reference><Reference><Citation>Groarke J.M., Berry E., Graham-Wisener L., et al. Loneliness in the UK during the COVID-19 pandemic: Cross-sectional results from the COVID-19 Psychological wellbeing study. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7513993</ArticleId><ArticleId IdType="pubmed">32970764</ArticleId></ArticleIdList></Reference><Reference><Citation>Newlove-Delgado T.M.F., Williams T., Mandalia D., et al. NHS Digital; Leeds: 2022. Mental health of children and young people in England, 2022.</Citation></Reference><Reference><Citation>Nugawela M.D., Stephenson T., Shafran R., et al. Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test. BMC Med. 2022;20:465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9708506</ArticleId><ArticleId IdType="pubmed">36447237</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E., Altman D.G., Egger M., et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg. 2014;12:1495&#x2013;1499.</Citation><ArticleIdList><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Shafran R., De Stavola B., et al. Long COVID and the mental and physical health of children and young people: National matched cohort study protocol (the CLoCk study) BMJ Open. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Maskell K., Bannister P.G., et al. Addressing challenges for clinical research responses to emerging epidemics and pandemics: A scoping review. BMC Med. 2020;18:190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7315698</ArticleId><ArticleId IdType="pubmed">32586391</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M., Gudex C., Lloyd A., et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20:1727&#x2013;1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Fat L., Scholes S., Boniface S., et al. Evaluating and establishing national norms for mental wellbeing using the short Warwick-Edinburgh mental well-being scale (SWEMWBS): Findings from the health survey for England. Qual Life Res. 2017;26:1129&#x2013;1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5376387</ArticleId><ArticleId IdType="pubmed">27853963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: Validity of a brief depression severity measure. J&#xa0;Gen Intern Med. 2001;16:606&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer R.L., Kroenke K., Williams J.B., et al. A&#xa0;brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166:1092&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell D.W. UCLA loneliness scale (version 3): Reliability, validity, and factor structure. J&#xa0;Pers Assess. 1996;66:20&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">8576833</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T., Berelowitz G., Pawlikowska T., et al. Development of a fatigue scale. J&#xa0;Psychosom Res. 1993;37:147&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer F., Manea L., Trepel D., et al. Screening for anxiety disorders with the GAD-7 and GAD-2: A systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">26719105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz A., Klein A.M., Br&#xe4;hler E., et al. Psychometric evaluation of the generalized anxiety disorder screener GAD-7, based on a large German general population sample. J&#xa0;Affect Disord. 2017;210:338&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">28088111</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong T.C.T., Chan J.S.M., Chan C.L.W., et al. Psychometric properties of the chalder fatigue scale revisited: An exploratory structural equation modeling approach. Qual Life Res. 2015;24:2273&#x2013;2278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4529874</ArticleId><ArticleId IdType="pubmed">25688039</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke A., Friede T., Putz R., et al. Warwick-edinburgh mental well-being scale (WEMWBS): Validated for teenage school students in England and&#xa0;Scotland. A mixed methods assessment. BMC Public Health. 2011;11:487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3141456</ArticleId><ArticleId IdType="pubmed">21693055</ArticleId></ArticleIdList></Reference><Reference><Citation>Koushede V., Lasgaard M., Hinrichsen C., et al. Measuring mental well-being in Denmark: Validation of the original and short version of the Warwick-Edinburgh mental well-being scale (WEMWBS and SWEMWBS) and cross-cultural comparison across four European settings. Psychiatry Res. 2019;271:502&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">30551082</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y.-S., Kohlmann T., Janssen M.F., et al. Psychometric properties of the EQ-5D-5L: A systematic review of the literature. Qual Life Res. 2021;30:647&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7952346</ArticleId><ArticleId IdType="pubmed">33284428</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., et al. Long COVID (post-COVID-19 condition) in children: A modified Delphi process. Arch Dis Child. 2022;107:674&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Housing C.L.G. The english indices of deprivation. https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015 Available at:</Citation></Reference><Reference><Citation>Amin-Chowdhury Z., Ladhani S.N. Causation or confounding: Why controls are critical for characterizing long COVID. Nat Med. 2021;27:1129&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Findlay S.M. The tired teen: A review of the assessment and management of the adolescent with sleepiness and fatigue. Paediatr Child Health. 2008;13:37&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2528817</ArticleId><ArticleId IdType="pubmed">19119351</ArticleId></ArticleIdList></Reference><Reference><Citation>Shevlin M., Butter S., McBride O., et al. Measurement invariance of the Patient health questionnaire (PHQ-9) and generalized anxiety disorder scale (GAD-7) across four European countries during the COVID-19 pandemic. BMC Psychiatry. 2022;22:154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8886334</ArticleId><ArticleId IdType="pubmed">35232409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lallukka T., Pietil&#xe4;inen O., J&#xe4;ppinen S., et al. Factors associated with health survey response among young employees: A register-based study using online, mailed and telephone interview data collection methods. BMC Public Health. 2020;20:184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7003443</ArticleId><ArticleId IdType="pubmed">32024488</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>